Overview

Treating Corneal Thinning Conditions With CCL Vario Riboflavin (CXL)

Status:
Not yet recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
Study is testing the efficacy of treating corneal thinning conditions with Vitamin B2 (Riboflavin) and the application on UV Light.
Phase:
Early Phase 1
Details
Lead Sponsor:
Kent Wellish MD
Treatments:
Riboflavin